DeepAI AI Chat
Log In Sign Up

Patient-reported outcomes in the context of the benefit assessment in Germany

by   Sarah Böhme, et al.

Since the 2011 Act on the Reform of the Market for Medicinal Products, benefit dossiers are submitted by pharmaceutical companies to facilitate the Health Technology Assessment (HTA) appraisals in Germany. The Institute for Quality and Efficiency in Health Care conducts the added benefit assessment following their General Methods Paper, which was updated November 5, 2020. This White Paper is dedicated to patient-reported outcomes (PRO) to highlight their importance for the added benefit assessment. We focus on methodological aspects but consider also other relevant requirements and challenges, which are demanded by G-BA and IQWiG. The following topics will be presented and discussed: 1. Role of PRO in HTA decision making exemplary to benefit assessment in Germany 2. Guidances of PRO evaluations 3. PRO Estimand framework 4. Perception and requirements for PRO within the German benefit assessment 5. Validity of instrument 6. Response thresholds for assessing clinical relevance of PRO 7. PRO endpoints / outcome measures / operationalization 8. Missing PRO data 9. PRO after treatment discontinuation This White Paper aims to provide deeper insights about new requirements concerning PRO evaluations for HTA decision making in Germany, highlight points to consider that should inform global development in terms of study planning and frame the requirements also in the context of global recommendations and guidelines. We also aim to enhance the understanding of the complexity when preparing the benefit dossier and promote further scientific discussions where appropriate.


page 11

page 12

page 13

page 16

page 20

page 21

page 26

page 32


Composer: Visual Cohort Analysis of Patient Outcomes

Visual cohort analysis utilizing electronic health record (EHR) data has...

Modelling Cooperation in a Dynamic Healthcare System

Our research is concerned with studying behavioural changes within a dyn...

FHIRChain: Applying Blockchain to Securely and Scalably Share Clinical Data

Secure and scalable data sharing is essential for collaborative clinical...

Net benefit, calibration, threshold selection, and training objectives for algorithmic fairness in healthcare

A growing body of work uses the paradigm of algorithmic fairness to fram...

Nine Recommendations for Decision Aid Implementation from the Clinician Perspective

Background: Shared decision-making (SDM) aims to empower patients to tak...

The Role of Normware in Trustworthy and Explainable AI

For being potentially destructive, in practice incomprehensible and for ...